Granules India, 532482, GRANULES Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

10,703.45
22.34
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

11,496.14
0.34%
3.02

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

13.30
11.64
6.18

EBITDA CAGR (%)

10 Years
5 Years
3 Years

15.16
10.26
3.47

PAT CAGR (%)

10 Years
5 Years
3 Years

16.12
5.51
-0.61

P:E (Median)

8 Years
5 Years
3 Years

17.11
18.08
20.70

P:BV (Average)

8 Years
5 Years
3 Years

2.99
3.47
3.24

EV:EBITDA (Average)

8 Years
5 Years
3 Years

11.15
11.80
12.07

Earnings Forecasts:

Description 2024 2025 2026 2027
Adj EPS 16.73 21.76 27.5 33.63
P/E Ratio 34.84 26.78 21.2 17.33
Revenue 3755 4711 5409 6116
EBITDA 856 1016 1219 1453
Net Income 405 528 668 814
ROA 9.2
P/B Ratio 4.37 3.81 3.27 2.81
ROE 13.38 14.54 15.74 16.92
FCFF -41.06 309.44 245.95 330.47
FCFF Yield -0.27 2.02 1.6 2.15

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 842.20 984.49 -14.45% 567.99 1,009.41 -43.73% 851.95 821.00 3.77% 940.19 1,013.88 -7.27%
Expenses 674.33 737.60 -8.58% 465.39 800.99 -41.90% 674.54 664.23 1.55% 750.91 796.58 -5.73%
EBITDA 167.87 246.88 -32.00% 102.60 208.42 -50.77% 177.41 156.77 13.17% 189.28 217.30 -12.89%
EBIDTM 19.93% 25.08% 18.06% 20.65% 20.82% 19.10% 20.13% 21.43%
Other Income 5.61 0.67 737.31% 2.78 1.25 122.40% 1.81 0.44 311.36% 3.42 2.56 33.59%
Interest 17.21 19.78 -12.99% 14.56 17.65 -17.51% 17.52 14.79 18.46% 19.79 14.12 40.16%
Depreciation 37.66 36.16 4.15% 34.75 36.01 -3.50% 35.85 35.27 1.64% 36.41 37.77 -3.60%
PBT 118.60 191.61 -38.10% 56.07 156.01 -64.06% 125.86 107.16 17.45% 136.51 167.97 -18.73%
Tax 28.49 48.91 -41.75% 14.68 39.86 -63.17% 32.08 27.31 17.47% 39.30 42.68 -7.92%
PAT 90.11 142.70 -36.85% 41.39 116.16 -64.37% 93.78 79.84 17.46% 97.22 125.29 -22.40%
PATM 10.70% 14.50% 7.29% 11.51% 11.01% 9.72% 10.34% 12.36%
EPS 3.72 5.88 -36.73% 1.71 4.79 -64.30% 3.87 3.29 17.63% 4.01 5.17 -22.44%

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 1,137.70 1,155.58 -1.55% 966.62 1,189.49 -18.74% 1,179.87 985.52 19.72% 1,175.78 1,195.50 -1.65%
Expenses 907.40 905.10 0.25% 763.30 976.51 -21.83% 920.60 848.69 8.47% 920.08 967.38 -4.89%
EBITDA 230.29 250.48 -8.06% 203.32 212.97 -4.53% 259.27 136.82 89.50% 255.70 228.12 12.09%
EBIDTM 20.24% 21.68% 21.03% 17.90% 21.97% 13.88% 21.75% 19.08%
Other Income 5.68 0.65 773.85% 3.25 1.53 112.42% 2.06 0.35 488.57% 1.87 3.38 -44.67%
Interest 26.57 28.65 -7.26% 25.67 25.96 -1.12% 27.02 22.46 20.30% 28.76 18.80 52.98%
Depreciation 56.61 52.39 8.05% 52.52 52.52 0.00% 52.87 49.24 7.37% 53.18 48.71 9.18%
PBT 152.79 170.09 -10.17% 128.38 136.02 -5.62% 181.44 65.47 177.13% 175.64 163.99 7.10%
Tax 35.19 44.44 -20.81% 31.15 33.91 -8.14% 46.79 17.58 166.15% 45.99 44.38 3.63%
PAT 117.60 125.65 -6.41% 97.23 102.12 -4.79% 134.65 47.89 181.17% 129.65 119.60 8.40%
PATM 10.34% 10.87% 10.06% 8.58% 11.41% 4.86% 11.03% 10.00%
EPS 4.85 5.18 -6.37% 4.01 4.21 -4.75% 5.56 1.98 180.81% 5.35 4.94 8.30%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 3,202.33 3,755.09 3,931.20 3,238.44 3,134.98 2,309.93 2,098.43 1,646.64 1,349.48 1,327.74 1,213.31 Net Sales Growth -16.36% -4.48% 21.39% 3.30% 35.72% 10.08% 27.44% 22.02% 1.64% 9.43% Cost Of Goods Sold 1,449.45 1,906.91 2,161.45 1,757.75 1,509.64 1,221.98 1,250.31 903.09 658.58 729.65 707.21 Gross Profit 1,752.88 1,848.17 1,769.75 1,480.69 1,625.34 1,087.94 848.11 743.55 690.90 598.09 506.10 GP Margin 54.74% 49.22% 45.02% 45.72% 51.85% 47.10% 40.42% 45.16% 51.20% 45.05% 41.71% Total Expenditure 2,565.17 2,953.73 3,095.91 2,594.40 2,273.61 1,815.79 1,766.08 1,353.12 1,053.68 1,058.15 1,003.53 Power & Fuel Cost - 93.01 88.94 69.91 65.51 57.00 54.94 48.22 38.67 34.97 36.32 % Of Sales - 2.48% 2.26% 2.16% 2.09% 2.47% 2.62% 2.93% 2.87% 2.63% 2.99% Employee Cost - 332.99 278.19 247.86 234.36 192.51 167.00 147.92 125.81 106.34 89.23 % Of Sales - 8.87% 7.08% 7.65% 7.48% 8.33% 7.96% 8.98% 9.32% 8.01% 7.35% Manufacturing Exp. - 270.58 205.25 221.01 167.94 138.10 118.49 103.97 82.92 64.50 45.62 % Of Sales - 7.21% 5.22% 6.82% 5.36% 5.98% 5.65% 6.31% 6.14% 4.86% 3.76% General & Admin Exp. - 133.95 125.56 91.19 139.16 94.21 74.55 65.30 58.05 54.46 53.52 % Of Sales - 3.57% 3.19% 2.82% 4.44% 4.08% 3.55% 3.97% 4.30% 4.10% 4.41% Selling & Distn. Exp. - 166.59 206.74 173.76 124.16 88.95 81.21 76.49 74.78 63.44 69.40 % Of Sales - 4.44% 5.26% 5.37% 3.96% 3.85% 3.87% 4.65% 5.54% 4.78% 5.72% Miscellaneous Exp. - 49.69 29.78 32.92 32.83 23.03 19.57 8.13 14.88 4.80 69.40 % Of Sales - 1.32% 0.76% 1.02% 1.05% 1.00% 0.93% 0.49% 1.10% 0.36% 0.18% EBITDA 637.16 801.36 835.29 644.04 861.37 494.14 332.35 293.52 295.80 269.59 209.78 EBITDA Margin 19.90% 21.34% 21.25% 19.89% 27.48% 21.39% 15.84% 17.83% 21.92% 20.30% 17.29% Other Income 13.62 5.78 12.88 18.12 13.72 26.46 28.49 23.77 14.52 6.67 2.96 Interest 69.08 72.00 38.67 16.35 23.77 26.86 28.36 32.93 32.16 37.05 30.93 Depreciation 144.67 143.85 145.56 126.16 118.45 101.82 90.77 75.92 71.35 58.25 49.56 PBT 437.04 591.29 663.94 519.65 732.87 391.91 241.71 208.45 206.80 180.96 132.26 Tax 114.55 155.37 165.16 133.13 180.09 108.96 79.87 69.29 63.98 60.18 37.03 Tax Rate 26.21% 26.28% 24.88% 25.62% 24.57% 19.70% 33.04% 33.24% 30.94% 33.26% 28.00% PAT 322.50 435.92 498.79 386.52 552.78 444.07 161.84 139.16 142.83 120.78 95.23 PAT before Minority Interest 322.50 435.92 498.79 386.52 552.78 444.07 161.84 139.16 142.83 120.78 95.23 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 10.07% 11.61% 12.69% 11.94% 17.63% 19.22% 7.71% 8.45% 10.58% 9.10% 7.85% PAT Growth -30.49% -12.60% 29.05% -30.08% 24.48% 174.39% 16.30% -2.57% 18.26% 26.83% EPS 13.30 17.98 20.57 15.94 22.80 18.31 6.67 5.74 5.89 4.98 3.93

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 4,459.97 4,506.37 4,511.92 3,764.92 3,237.54 2,598.65 2,279.20 1,684.62 1,410.57 1,357.18 1,292.92 Net Sales Growth -1.46% -0.12% 19.84% 16.29% 24.59% 14.02% 35.29% 19.43% 3.93% 4.97% Cost Of Goods Sold 1,756.95 2,021.25 2,307.28 1,883.64 1,391.28 1,280.93 1,255.56 896.32 679.63 725.03 746.95 Gross Profit 2,703.02 2,485.12 2,204.63 1,881.28 1,846.27 1,317.72 1,023.64 788.30 730.93 632.15 545.97 GP Margin 60.61% 55.15% 48.86% 49.97% 57.03% 50.71% 44.91% 46.79% 51.82% 46.58% 42.23% Total Expenditure 3,511.38 3,650.39 3,598.60 3,043.30 2,382.31 2,073.33 1,895.16 1,406.20 1,111.73 1,081.29 1,084.31 Power & Fuel Cost - 100.64 95.69 74.66 68.85 59.74 57.67 48.22 38.67 34.97 45.73 % Of Sales - 2.23% 2.12% 1.98% 2.13% 2.30% 2.53% 2.86% 2.74% 2.58% 3.54% Employee Cost - 550.24 420.35 366.44 324.29 259.04 209.82 165.21 140.19 117.57 106.96 % Of Sales - 12.21% 9.32% 9.73% 10.02% 9.97% 9.21% 9.81% 9.94% 8.66% 8.27% Manufacturing Exp. - 408.01 273.93 298.74 228.39 177.94 157.62 120.84 88.60 66.97 50.89 % Of Sales - 9.05% 6.07% 7.93% 7.05% 6.85% 6.92% 7.17% 6.28% 4.93% 3.94% General & Admin Exp. - 211.99 187.96 134.41 172.28 125.63 99.96 83.05 67.65 60.38 59.84 % Of Sales - 4.70% 4.17% 3.57% 5.32% 4.83% 4.39% 4.93% 4.80% 4.45% 4.63% Selling & Distn. Exp. - 290.63 280.00 247.45 159.80 112.17 91.84 83.08 81.37 67.75 71.70 % Of Sales - 6.45% 6.21% 6.57% 4.94% 4.32% 4.03% 4.93% 5.77% 4.99% 5.55% Miscellaneous Exp. - 67.62 33.38 37.96 37.42 57.88 22.69 9.49 15.61 8.62 71.70 % Of Sales - 1.50% 0.74% 1.01% 1.16% 2.23% 1.00% 0.56% 1.11% 0.64% 0.17% EBITDA 948.58 855.98 913.32 721.62 855.23 525.32 384.04 278.42 298.84 275.89 208.61 EBITDA Margin 21.27% 18.99% 20.24% 19.17% 26.42% 20.22% 16.85% 16.53% 21.19% 20.33% 16.13% Other Income 12.86 4.40 14.29 18.22 26.88 36.56 26.68 10.84 9.93 5.62 4.34 Interest 108.02 105.82 55.93 23.21 26.28 27.02 28.46 33.06 32.26 37.07 32.35 Depreciation 215.18 207.33 184.49 158.63 151.46 136.95 105.48 76.20 71.51 58.40 52.65 PBT 638.25 547.23 687.17 558.00 704.36 397.90 276.78 180.00 204.99 186.03 127.96 Tax 159.12 141.92 170.58 145.24 154.91 115.73 89.11 63.40 65.20 61.15 37.05 Tax Rate 24.93% 25.93% 24.82% 26.03% 21.99% 27.19% 32.20% 35.22% 31.81% 32.87% 28.95% PAT 479.13 405.31 516.60 412.76 549.46 309.91 187.67 116.60 139.79 124.89 90.91 PAT before Minority Interest 479.13 405.31 516.60 412.76 549.46 309.91 187.67 116.60 139.79 124.89 90.91 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 10.74% 8.99% 11.45% 10.96% 16.97% 11.93% 8.23% 6.92% 9.91% 9.20% 7.03% PAT Growth 21.22% -21.54% 25.16% -24.88% 77.30% 65.14% 60.95% -16.59% 11.93% 37.38% EPS 19.76 16.71 21.30 17.02 22.66 12.78 7.74 4.81 5.76 5.15 3.75

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 3,110.95 2,699.46 2,530.66 2,162.62 1,811.59 1,423.24 1,278.20 884.36 664.50 425.41 Share Capital 24.24 24.20 24.80 24.77 25.42 25.42 25.38 22.87 21.67 20.43 Total Reserves 3,073.00 2,661.83 2,493.62 2,127.56 1,777.38 1,391.01 1,247.40 859.04 614.03 404.98 Non-Current Liabilities 126.13 210.04 300.36 391.88 487.14 558.30 503.65 195.52 252.93 299.92 Secured Loans 50.01 148.64 233.70 333.81 414.83 478.78 433.13 123.90 183.66 242.05 Unsecured Loans 0.00 0.00 0.00 0.00 6.08 0.00 0.00 0.34 0.55 0.62 Long Term Provisions 37.86 29.26 28.31 24.84 21.50 12.58 7.70 7.25 5.58 3.97 Current Liabilities 1,768.55 1,593.77 1,541.60 1,128.33 847.45 842.84 856.95 775.09 650.46 381.39 Trade Payables 654.63 744.39 606.80 507.65 322.88 276.89 260.54 209.90 177.15 183.24 Other Current Liabilities 193.63 162.67 180.39 183.49 143.48 106.55 62.90 89.76 78.87 69.84 Short Term Borrowings 904.23 663.08 720.04 409.27 371.69 454.21 525.10 473.83 392.85 114.87 Short Term Provisions 16.06 23.63 34.37 27.92 9.41 5.20 8.41 1.60 1.58 13.45 Total Liabilities 5,005.63 4,503.27 4,372.62 3,682.83 3,146.18 2,824.38 2,638.80 1,854.97 1,567.89 1,106.72 Net Block 1,323.67 1,329.80 1,170.83 985.00 926.88 699.95 660.15 605.58 523.29 522.17 Gross Block 2,312.27 2,200.71 1,949.12 1,693.02 1,522.83 1,195.01 1,065.65 937.36 784.53 725.69 Accumulated Depreciation 988.60 870.91 778.29 708.02 595.94 495.06 405.50 331.78 261.24 203.53 Non Current Assets 2,371.70 2,185.30 2,041.97 1,804.97 1,671.30 1,615.46 1,460.30 1,021.47 747.81 631.99 Capital Work in Progress 52.94 63.46 210.52 164.01 129.78 333.03 286.03 132.31 35.28 18.50 Non Current Investment 941.40 676.53 596.53 591.53 445.39 506.46 75.12 75.11 88.95 72.47 Long Term Loans & Adv. 53.70 115.52 64.08 64.42 169.24 76.02 439.00 208.47 100.30 18.70 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.15 Current Assets 2,633.92 2,317.97 2,330.65 1,877.87 1,474.88 1,208.91 1,178.50 833.50 820.08 473.05 Current Investments 0.00 0.00 0.00 0.00 109.85 0.00 0.00 0.00 0.00 0.00 Inventories 578.62 593.41 590.74 461.70 343.95 314.14 227.36 237.59 210.13 179.40 Sundry Debtors 1,633.19 1,372.19 1,210.43 1,014.24 627.00 704.21 692.91 468.31 444.16 194.09 Cash & Bank 228.11 202.98 355.09 241.23 272.34 62.44 97.41 39.36 110.70 52.23 Other Current Assets 194.01 36.47 54.19 48.15 121.74 128.13 160.82 88.23 55.09 47.33 Short Term Loans & Adv. 157.26 112.91 120.21 112.56 81.37 92.25 113.52 49.24 45.75 1.78 Net Current Assets 865.37 724.20 789.06 749.53 627.43 366.07 321.55 58.40 169.63 91.66 Total Assets 5,005.62 4,503.27 4,372.62 3,682.84 3,146.18 2,824.37 2,638.80 1,854.97 1,567.89 1,106.73

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 3,225.54 2,834.91 2,586.54 2,173.27 1,843.72 1,529.47 1,304.18 903.60 661.60 431.16 Share Capital 24.24 24.20 24.80 24.77 25.42 25.42 25.38 22.87 21.67 20.43 Total Reserves 3,183.00 2,792.68 2,545.01 2,126.23 1,800.02 1,493.09 1,273.38 878.28 611.13 410.74 Non-Current Liabilities 176.04 254.73 282.83 366.30 485.98 552.63 488.19 187.99 246.62 356.52 Secured Loans 68.97 148.64 233.70 333.81 414.83 478.78 433.13 123.90 183.66 302.59 Unsecured Loans 0.00 0.00 0.00 0.00 6.69 0.00 0.00 0.34 0.55 0.62 Long Term Provisions 37.88 29.26 28.31 24.84 21.50 12.58 7.70 7.25 5.58 4.03 Current Liabilities 2,082.29 1,813.50 1,641.60 1,173.10 893.40 896.48 877.91 787.13 654.75 415.03 Trade Payables 749.53 782.13 638.61 541.05 356.88 323.48 274.35 215.98 181.10 187.63 Other Current Liabilities 261.08 193.19 200.85 194.25 153.16 113.60 69.84 93.43 79.21 88.98 Short Term Borrowings 1,054.24 810.88 765.58 409.27 371.69 454.21 525.10 473.83 392.85 124.97 Short Term Provisions 17.45 27.31 36.56 28.53 11.66 5.20 8.62 3.90 1.58 13.45 Total Liabilities 5,483.87 4,903.14 4,511.53 3,712.67 3,223.10 2,978.58 2,670.28 1,878.72 1,562.97 1,202.71 Net Block 2,095.62 1,910.92 1,541.17 1,332.00 1,203.97 944.25 776.73 644.34 559.94 616.55 Gross Block 3,351.81 2,981.22 2,461.77 2,145.15 1,875.23 1,472.94 1,199.63 983.66 822.98 843.76 Accumulated Depreciation 1,256.19 1,070.30 920.59 813.15 671.26 528.69 422.90 339.32 263.05 227.21 Non Current Assets 2,578.83 2,328.99 2,006.54 1,715.68 1,594.41 1,696.34 1,483.71 1,050.55 744.97 699.69 Capital Work in Progress 271.70 239.39 356.23 239.08 294.20 495.95 514.52 267.43 76.56 62.03 Non Current Investment 21.52 21.21 19.67 18.99 19.34 210.42 156.56 108.23 70.11 0.19 Long Term Loans & Adv. 190.00 157.47 89.47 125.61 76.89 45.72 35.91 30.56 38.37 20.76 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.15 Current Assets 2,905.05 2,574.15 2,504.99 1,997.00 1,628.70 1,282.24 1,186.57 828.16 818.00 500.36 Current Investments 0.00 0.00 0.00 0.00 109.85 0.00 0.00 0.00 0.00 0.00 Inventories 1,300.55 1,149.41 978.55 782.18 438.43 384.21 279.95 269.18 253.72 224.52 Sundry Debtors 985.83 948.54 924.95 765.42 662.04 673.54 628.25 417.70 375.35 136.91 Cash & Bank 386.38 312.79 409.46 271.04 283.94 89.04 115.64 49.80 130.29 65.31 Other Current Assets 232.28 49.22 61.67 50.74 134.43 135.45 162.73 91.49 58.65 73.63 Short Term Loans & Adv. 186.00 114.19 130.35 127.61 91.83 98.46 114.09 51.66 48.68 2.05 Net Current Assets 822.75 760.65 863.38 823.90 735.30 385.76 308.65 41.03 163.25 85.33 Total Assets 5,483.88 4,903.14 4,511.53 3,712.68 3,223.11 2,978.58 2,670.28 1,878.71 1,562.97 1,202.72

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 316.93 663.68 280.29 374.66 494.79 226.85 23.98 190.14 143.98 134.98 PBT 591.29 663.94 519.65 732.87 553.03 241.71 208.45 206.80 180.96 132.26 Adjustment 229.36 178.19 137.11 153.72 -53.91 121.92 91.94 94.81 90.88 80.91 Changes in Working Capital -346.65 -1.30 -233.77 -325.99 115.30 -49.97 -222.92 -52.64 -80.27 -46.95 Cash after chg. in Working capital 474.00 840.82 422.99 560.60 614.42 313.66 77.47 248.97 191.57 166.22 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -157.07 -177.14 -142.70 -185.94 -119.63 -86.80 -53.49 -58.83 -47.59 -31.24 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -302.98 -96.45 -318.45 -232.62 -164.80 -242.91 -494.86 -299.57 -171.22 -130.28 Net Fixed Assets -101.04 -104.53 -302.61 -204.42 -124.57 -176.36 -282.01 -249.86 -75.62 -231.53 Net Investments -264.87 -80.00 -5.00 -36.29 -48.78 -431.34 -0.01 13.84 -16.48 72.98 Others 62.93 88.08 -10.84 8.09 8.55 364.79 -212.84 -63.55 -79.12 28.27 Cash from Financing Activity 26.14 -519.47 151.43 -296.21 -212.29 -17.33 528.75 36.23 85.70 24.87 Net Cash Inflow / Outflow 40.10 47.76 113.27 -154.17 117.70 -33.39 57.87 -73.20 58.47 29.56 Opening Cash & Equivalents 181.75 134.24 20.03 174.32 56.42 89.81 31.94 104.76 52.23 22.67 Closing Cash & Equivalent 223.08 181.75 134.24 20.03 174.32 56.42 89.81 31.94 110.70 52.23

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 439.41 738.75 332.06 432.48 476.19 262.24 -0.65 188.24 151.43 150.28 PBT 547.23 687.17 558.00 704.36 425.64 276.78 180.00 204.99 186.03 127.96 Adjustment 328.80 237.69 176.29 194.43 156.88 149.85 107.45 95.14 92.63 85.37 Changes in Working Capital -246.32 -10.31 -257.19 -274.95 12.75 -75.94 -230.03 -52.37 -79.70 -31.34 Cash after chg. in Working capital 629.71 914.55 477.11 623.84 595.27 350.69 57.42 247.77 198.97 182.00 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -190.30 -175.80 -145.05 -191.37 -119.08 -88.45 -58.07 -59.53 -47.54 -31.72 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -360.16 -191.36 -380.12 -277.13 -160.63 -269.82 -462.31 -326.09 -161.65 -145.55 Net Fixed Assets -101.04 -104.53 -302.61 -204.42 -124.57 -176.36 -282.01 -249.86 -75.62 -231.53 Net Investments -264.87 -80.00 -5.00 -36.29 -48.78 -431.34 -0.01 13.84 -16.48 72.98 Others 5.75 -6.83 -72.51 -36.42 12.72 337.88 -180.29 -90.07 -69.55 13.00 Cash from Financing Activity 7.66 -440.29 190.00 -299.31 -212.85 -17.43 528.62 55.87 85.67 18.83 Net Cash Inflow / Outflow 86.92 107.10 141.94 -143.97 102.70 -25.01 65.66 -81.98 75.44 23.56 Opening Cash & Equivalents 291.56 184.71 41.84 185.93 83.02 108.03 42.37 124.35 54.85 41.75 Closing Cash & Equivalent 381.10 291.56 184.71 41.84 185.93 83.02 108.03 42.37 130.29 65.31

Financial Ratios

Consolidated /

Standalone

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 127.79 110.97 101.55 86.90 70.91 55.71 50.14 38.56 29.33 20.75 ROA 9.17% 11.24% 9.60% 16.19% 14.88% 5.92% 6.19% 8.35% 9.03% 9.73% ROE 15.08% 19.17% 16.55% 27.95% 27.59% 12.04% 12.92% 18.82% 22.80% 24.88% ROCE 17.06% 19.55% 16.29% 26.53% 22.67% 11.56% 12.71% 16.79% 20.36% 21.63% Fixed Asset Turnover 1.66 1.89 1.78 1.98 1.71 1.87 1.65 1.60 1.79 2.08 Receivable days 146.06 119.89 125.37 93.87 104.53 120.48 128.14 121.18 86.06 45.56 Inventory Days 56.96 54.97 59.31 46.08 51.67 46.70 51.31 59.46 52.52 43.81 Payable days 133.89 114.09 115.71 100.40 57.71 53.12 62.58 65.51 60.24 56.59 Cash Conversion Cycle 69.13 60.78 68.97 39.55 98.49 114.06 116.87 115.13 78.34 32.79 Total Debt/Equity 0.34 0.34 0.42 0.39 0.49 0.70 0.77 0.74 1.01 0.98 Interest Cover 9.21 18.17 32.78 31.83 21.59 9.52 7.33 7.43 5.88 5.28

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 132.33 116.38 103.62 86.85 71.80 59.73 51.17 39.40 29.20 20.98 ROA 7.80% 10.97% 10.04% 15.84% 9.99% 6.64% 5.13% 8.12% 9.03% 8.31% ROE 13.46% 19.18% 17.49% 27.64% 18.54% 13.32% 10.60% 18.23% 23.53% 23.29% ROCE 15.66% 19.63% 17.37% 25.42% 17.22% 12.71% 11.09% 16.57% 20.16% 18.75% Fixed Asset Turnover 1.42 1.66 1.63 1.97 1.75 1.78 1.55 1.59 1.66 1.77 Receivable days 78.34 75.78 81.94 65.94 83.34 100.03 112.83 100.84 67.60 33.47 Inventory Days 99.22 86.07 85.35 56.39 51.34 51.03 59.23 66.49 63.11 54.79 Payable days 138.29 112.38 114.29 117.79 58.20 54.96 62.37 64.87 59.99 53.57 Cash Conversion Cycle 39.26 49.48 52.99 4.54 76.48 96.10 109.70 102.46 70.72 34.69 Total Debt/Equity 0.38 0.38 0.43 0.39 0.49 0.65 0.75 0.73 1.01 1.14 Interest Cover 6.17 13.29 25.04 27.80 16.75 10.72 6.44 7.36 6.02 4.96

Top Investors:

life insurance corporation of india

sbi life insurance co. ltd

axis mutual fund trustee limited a/c axis mutual f

aditya birla sun life trustee private limited a/c

kotak mahindra life insurance company ltd

schroder international selection fund global emerg

edelweiss trusteeship co ltd ac- edelweiss mf ac-

tata mid cap growth fund

basava sankara rao kolli

investor education and protection fund (iepf)

Annual Reports:

News Update:

Granules India acquires Senn Chemicals AG
11th Apr 2025, 12:12 PM

The company has forayed into the CDMO space with the acquisition of Senn Chemicals AG
Read More
Granules India signs agreement to acquire Senn Chemicals AG
22nd Feb 2025, 11:08 AM

This acquisition enables Granules’ acquiring capabilities into high-growth peptide-based therapeutics
Read More
Granules India’s arm gets USFDA’s nod for Lisdexamfetamine Dimesylate capsules
30th Jan 2025, 15:30 PM

With this latest approval, the company now holds a total of 69 ANDA approvals, with 38 secured under the name of GIL and 31 under GPI
Read More
Granules India gets EU GMP certificate for Unit V facility in Andhra Pradesh
30th Jan 2025, 12:09 PM

The company has received EU GMP certificate for APIs and FDs
Read More

Granules India Ltd.

Pharmaceuticals & Drugs - API

BSE: 532482 | NSE: GRANULES

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Granules India Ltd.

Pharmaceuticals & Drugs - API

BSE: 532482 | NSE: GRANULES

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: